Caption Management’s SpringWorks Therapeutics SWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-297,500
Closed -$14M 2025
2025
Q2
$14M Buy
297,500
+18,500
+7% +$823K 0.15% 137
2025
Q1
$12.3M Buy
+279,000
New +$12.8M 0.12% 156
2024
Q1
Sell
-337,900
Closed -$12.3M 1654
2023
Q4
$12.3M Buy
+337,900
New +$8.82M 0.17% 153
2023
Q2
Sell
-130,000
Closed -$3.35M 1395
2023
Q1
$3.35M Sell
130,000
-250,000
-66% -$7.31M 0.06% 320
2022
Q4
$9.88M Buy
380,000
+195,500
+106% +$4.82M 0.15% 168
2022
Q3
$5.26M Buy
+184,500
New +$5.29M 0.07% 328
2022
Q2
Sell
-77,500
Closed -$4.37M 1816
2022
Q1
$4.37M Buy
+77,500
New +$4.44M 0.05% 479

Other funds holding SWTX

Caption Management's SWTX Position: Q2 2025 in Review

Caption Management sold out of SpringWorks Therapeutics (SWTX) in Q2 2025, closing a stake of 116,994 shares — an estimated $5.2M sold.

Caption Management first reported a position in SWTX in Q1 2022 and held it in 4 quarters. The position peaked at $5.16M in Q1 2025. 222 funds tracked by Wall St. Rank hold SWTX as of Q2 2025.

  • Caption Management reported no remaining SpringWorks Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Caption Management sold 116,994 SpringWorks Therapeutics shares in Q2 2025, an estimated $5.2M.
  • Caption Management first reported a position in SpringWorks Therapeutics in Q1 2022 and held it in 4 quarters.
  • Caption Management's SpringWorks Therapeutics position peaked at $5.16M in Q1 2025.
  • 222 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2025.

Based on Caption Management's 13F filing for Q2 2025, filed 14 Aug 2025.